In SeekingAlpha ETFs - Posted 2 weeks ago

Last week was the quarterly high watermark for earnings announcements in China Biotech. As a basic theme, the reports seemed each in their own way to ...

Tags: biotech china earnings

In SeekingAlpha China Stocks - Posted 2 weeks ago

Last week was the quarterly high watermark for earnings announcements in China Biotech. As a basic theme, the reports seemed each in their own way to ...

Tags: china

In SeekingAlpha China Stocks - Posted 12 weeks ago

The news in China biotech last week revolved around two major topics: trial results/approvals and deals. On the test results front, Bridge Laboratorie...

Tags: beijing china

In SeekingAlpha ETFs - Posted 12 weeks ago

The news in China biotech last week revolved around two major topics: trial results/approvals and deals. On the test results front, Bridge Laboratorie...

Tags: beijing biotech china data pharma phase

In SeekingAlpha ETFs - Posted 13 weeks ago

Mindray Medical International Ltd. (MR)Q2 2008 Earnings Call...

Tags: earnings

In SeekingAlpha China Stocks - Posted 16 weeks ago

As an additional follow-up to my ADR series (see previous articles on energy sector ADRs and financial sector ADRS), I am going to take a look at the ...

Tags: chinese hong kong

In SeekingAlpha China Stocks - Posted 17 weeks ago

July was a volatile month for the U.S. markets. The Dow Jones Industrial Average started the month with some big losses, even closing below 11,000 for...

Tags: china shanghai

In SeekingAlpha China Stocks - Posted 22 weeks ago

Comparing to what happened to Chinese stocks listed on U. S. stock exchanges, the drop in major U. S. equity indexes is minor, though the Dow Jones In...

Tags: china chinese

In SeekingAlpha China Stocks - Posted 24 weeks ago

Last week, the news item that could have the most profound effect on the China biomedical world, did not paradoxically involve a China biomedi...

Tags: bse china chinese hong kong india nse

In SeekingAlpha ETFs - Posted 24 weeks ago

Last week, the news item that could have the most profound effect on the China biomedical world, did not paradoxically involve a China biomedi...

Tags: biotech bse china chinese clinical trial disease health hong kong india markets nse pharma

Featured Investment Blogs